
Interactive training to provide you with necessary skills to be a compliance leader within your organization.
MedTech Compliance Bootcamp
September 16, 2025 | 8:00 AM – 6:30 PM
September 17, 2025 | 8:00 AM – 2:00 PM
MedTech Compliance Bootcamp
September 16, 2025 | 8:00 AM – 6:30 PM
September 17, 2025 | 8:00 AM – 2:00 PM
Join us for the 2025 Compliance Bootcamp hosted by AdvaMed® and Porzio, September 16-17 in Washington, D.C.! This event is perfect for those who have recently taken on compliance responsibilities, are currently revamping an existing program, or just want a quick refresher. The carefully curated program will provide you with a comprehensive understanding of the current compliance framework; practical, hands-on approaches for addressing challenges and hurdles; and methods for effectively managing compliance within a medical technology company.
Secure your spot to ensure your team is up to speed on compliance issues and join our interest list to be the first to receive event updates.
Learning Objectives
- How to build and maintain an effective compliance program, as well as implement best practices.
- Group breakout sessions and interactive discussions of relevant hypothetical case studies.
- An in-depth look at major risk areas and compliance challenges and the ways to mitigate those risks.
- A holistic breakdown of the fundamentals of compliance.
This event is in partnership with:

2025 Agenda
DAY ONE – Tuesday, September 16th
Start Time | Topic/Details All Sessions Will Be Interactive Throughout |
---|---|
8:00 am | Breakfast |
8:30 am | Introduction Faculty Bios Program Overview Attendees’ Goals for This Program/Polling AdvaMed® Intro |
9:00 am | The Amorphous Power of Culture Impact of Culture on Compliance Pressure Points that Can Affect (and Change?) Culture |
9:45 am | What Interests The Government These Days Recent Government Enforcement Actions & Areas of Focus Lessons Learned and Their Relevance to Your Business New Developments |
10:45 am | Break |
11:00 am | Compliance Deep Dive (Part 1) Structure & Operation of Your Compliance Program Scope of Compliance Role & Cross-functional Responsibilities Motivating Senior Management and Educating the Board |
12:00 pm | Lunch |
1:00 pm | Compliance Deep Dive (Part 2): Identifying and Mitigating Ongoing and Emerging Risk Areas) Considerations related to Interactions and Engagements with HCPs and Other Individuals/Entities; External Funding; Reimbursement Activities; Managing Distributors; Other Compliance Challenges |
3:00 pm | Break |
3:15 pm | Interactive Break Out Session Present hypothetical scenarios and consider application of the AdvaMed® Code and other compliance considerations Conducting a compliance risk assessment |
5:15 pm | Review of Day One/Plan for Day Two |
5:30 pm | Adjourn Day One |
5:30 pm | Program Reception -TBD |
DAY TWO – Wednesday, September 17th
Start Time | Topic/Details All Sessions Will Be Interactive Throughout |
---|---|
8:00 am | Breakfast |
8:30 am | Recap of Day 1 and Interactive Q&A |
9:00 am | Managing Promotional, Medical, Corporate & Investor Communications (including Social Media): What You Can/Should/Shouldn’t Say to Whom Regulatory Requirements for Promotion Recent FDA and FTC Developments Key Considerations for Scientific Exchange, Disease Awareness and Corporate Communications Social Media and Considerations with Use of “Influencers” |
10:00 am | Industry Panel – Healthcare Compliance and All Its Glory in the Medical Device Business This session will involve current in-house Compliance Officers and AdvaMed® compliance leaders who will discuss the multifaceted considerations associated with managing and mitigating health care compliance risks in today’s medical device industry. |
11:30 am | AdvaMed® Update Patrick Fogarty, Deputy General Counsel and Senior Vice President, Legal, AdvaMed® Ida Nassar, Vice President, Assistant General Counsel, Compliance & Ethics, Legal, AdvaMed® |
12:15 pm | Lunch Break |
12:45 pm | Data Privacy, Use of AI and Related Topics Where We Are and What May Lie Ahead Key Data Privacy Considerations for Medical Devices Best Practices to Navigate the Dynamic Regulatory Landscapes of Data Privacy and AI |
1:45 pm | Closing Discussion, Q&A and Wrap-up Any Remaining (Burning) Questions So What Are You Going to Do When You Get Back to Work? |
2:00 pm | Adjourn Day Two |
In 2024 we welcomed speakers from Porzio, Bromberg & Newman, AdvaMed®, Vericel, Stryker Corporation and Terumo Americas. See confirmed 2025 speakers below.
2025 Speakers
Michelle D. Axelrod, J.D. Managing Principal of Porzio, Bromberg & Newman.

Michelle D. Axelrod is the Managing Principal of Porzio, Bromberg & Newman’s New England office. Michelle has over 25 years of experience addressing legal and compliance issues impacting companies in the life sciences industry; 15 years as in-house counsel. Michelle primarily counsels pharmaceutical, medical device, and biotech clients on legal and compliance issues related to product commercialization and related sales, marketing, and reimbursement activities. Michelle reviews promotional
content and medical communications, advises on fraud and abuse matters and related issues, provides direction regarding field and account management, and supports clients’ compliance initiatives, including the development of policies/SOPs, training, and monitoring and auditing programs. Michelle also negotiates, drafts and reviews commercial and government contracts, including discount and rebate agreements with health plans/PBMs, retail/specialty pharmacies, GPOs, wholesalers, and other healthcare entities. In addition, she handles distribution agreements and other fee-for-service consulting and service arrangements common in the life sciences industry.
Pat Fogarty, Esq., Deputy General Counsel, Senior Vice President of Legal, AdvaMed®

Pat Fogarty is the Deputy General Counsel & Senior VP of Legal at the Advanced Medical Technology Association® (AdvaMed®). AdvaMed® advocates globally for the highest ethical standards and patient access to safe, effective and innovative medical technologies that save and improve lives. In addition to providing in-house legal counsel to the organization, Pat leads AdvaMed®’s litigation reform legal policy work and related stakeholder outreach, which are emerging priorities for medtech innovators and patients who rely on FDA’s safety determinations. He also manages the association’s amicus curiae program, including filing multiple briefs on a myriad of issues in U.S. federal and state courts. Pat holds a B.A. from Virginia Tech and a J.D. from the Syracuse University College of Law. He is admitted to the District of Columbia Bar.
Ida Nassar, Esq., Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed®

Ms. Nassar manages AdvaMed®’s ethics and compliance policy working groups on the AdvaMed® Code, federal and state anti-kickback statutes, the Physician Self-Referral (Stark) Law, Sunshine Implementation, False Claims Act, and other health care laws and regulations applicable to medical device innovators and manufacturers. Ms. Nassar also handles AdvaMed®’s global legal policy working groups, which seek to establish common global standards for anti corruption and business integrity and secure procurement, regulatory, and enforcement incentives that reward compliance. Prior to AdvaMed®, Ms. Nassar was a Senior Attorney within the Drug Enforcement Administration’s Office of Chief Counsel where she handled enforcement actions under the Controlled Substances Act as well as defensive litigation matters for the department. She also served as Trial Attorney for the U.S. Department of Justice, managing commercial and torts litigation (including vaccine litigation). Ida also practiced for several years with the Hollingsworth law firm managing life sciences products liability litigation.
Jennifer Romanski, J.D., Principal, Porzio, Bromberg & Newman

Ms. Romanski, chair of the firm’s Life Sciences Legal, Regulatory, and Compliance Practice Group, has broad experience counseling pharmaceutical, biotech and medical device companies in regulatory and compliance matters, including preparation of corporate compliance programs, advertising and promotion activities, medical publication planning, interactions with healthcare practitioners, grants and continuing medical education programs, FDA enforcement activity, and sample accountability and PDMA requirements. She worked for many years in Porzio’s Key Client program where she served as part of the in-house legal team for various pharmaceutical companies several days a week. She has also served as acting compliance director at a large pharmaceutical company, where she was involved in over twenty compliance reviews and investigations.
Fred Brunetti, Principal, Porzio

Alfred R. Brunetti is a seasoned counselor who guides clients through the increasingly complex matrix of data privacy and security laws, regulations and guidance impacting business across all industries. Fred combines his in-depth knowledge of existing and emerging privacy laws and best practices with his extensive nationwide litigation and compliance experience to regularly advise clients, both large and small, on all manner of data privacy issues relating to the collection, processing and management of personal information throughout its life cycle.
He leads the firm’s Data Privacy Practice Group and is certified by the International Association of Privacy Professionals (IAPP) as both a Certified Information Privacy Professional in the laws of the United States (CIPP/US), a designation evidencing information privacy expertise with advanced concentration in domestic private sector laws, and a Certified Information Privacy Manager (CIPM), a designation evidencing expertise in the creation and management of a comprehensive privacy program.
Fred began his legal career as a law clerk for the Hon. Elaine L. Davis, P.J. Crim., in Hudson County, NJ, and then as an assistant prosecutor in the Union County Prosecutor’s Office in Elizabeth, NJ. He is a graduate of Seton Hall University and Seton Hall University School of Law, where he was an award-winning member of the Interscholastic Moot Court Board.
Registration Pricing
Check to see if your company is an AdvaMed® member here.
AdvaMed Accel® Member Companies: $975
AdvaMed® Member Companies: $1,920
Non-Members: $2,335
Government/Academic: $1,105
Location
AdvaMed® Office | 1301 Pennsylvania Ave NW, Washington, D.C. 20004
The two-day Compliance Bootcamp will take place in AdvaMed®’s office located in the heart of Washington, DC.